Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group).
Rougier P, van Pottelsberghe C, Kok T, Paillot B, Wagener T, De Greve J, Fabri MC, Gerard B, Van Glabbeke M, Bleiberg H. Rougier P, et al. Among authors: wagener t. Eur J Cancer. 1996 Jul;32A(8):1432-3. doi: 10.1016/0959-8049(96)00088-3. Eur J Cancer. 1996. PMID: 8869111 Clinical Trial.
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Ducreux M, Van Cutsem E, Van Laethem JL, Gress TM, Jeziorski K, Rougier P, Wagener T, Anak O, Baron B, Nordlinger B; EORTC Gastro Intestinal Tract Cancer Group. Ducreux M, et al. Among authors: wagener t. Eur J Cancer. 2005 Feb;41(3):398-403. doi: 10.1016/j.ejca.2004.10.026. Eur J Cancer. 2005. PMID: 15691639 Clinical Trial.
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study.
Blijham G, Wagener T, Wils J, de Greve J, Buset M, Bleiberg H, Lacave A, Dalmark M, Selleslag J, Collette L, Sahmoud T. Blijham G, et al. Among authors: wagener t. J Clin Oncol. 1996 Aug;14(8):2266-73. doi: 10.1200/JCO.1996.14.8.2266. J Clin Oncol. 1996. PMID: 8708716 Free article. Clinical Trial.
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Pinedo HM, Bramwell VH, Mouridsen HT, Somers R, Vendrik CP, Santoro A, Buesa J, Wagener T, van Oosterom AT, van Unnik JA, et al. Pinedo HM, et al. Among authors: wagener t. Cancer. 1984 May 1;53(9):1825-32. doi: 10.1002/1097-0142(19840501)53:9<1825::aid-cncr2820530904>3.0.co;2-z. Cancer. 1984. PMID: 6367947 Clinical Trial.
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
Lutz MP, Van Cutsem E, Wagener T, Van Laethem JL, Vanhoefer U, Wils JA, Gamelin E, Koehne CH, Arnaud JP, Mitry E, Husseini F, Reichardt P, El-Serafi M, Etienne PL, Lingenfelser T, Praet M, Genicot B, Debois M, Nordlinger B, Ducreux MP; European Organisation for Research and Treatment of Cancer Gastrointestinal Group. Lutz MP, et al. Among authors: wagener t. J Clin Oncol. 2005 Dec 20;23(36):9250-6. doi: 10.1200/JCO.2005.02.1980. J Clin Oncol. 2005. PMID: 16361622 Clinical Trial.
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G, van Oosterom A, Mouridsen HT, Bramwell V, Santoro A, Verweij J, Rouëssé J, Somers R, Wagener T, Buesa J, et al. Blackledge G, et al. Among authors: wagener t. Clin Oncol (R Coll Radiol). 1989 Nov;1(2):106-9. doi: 10.1016/s0936-6555(89)80045-7. Clin Oncol (R Coll Radiol). 1989. PMID: 2486477 Review. No abstract available.
205 results